Feasibility of Evaluating XSTAT Use in the Prehospital Setting

Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Dec 4, 2020

Keywords

ClinConnect Summary

The XSTAT® device injects small, rapidly-expanding cellulose sponges into the wound cavity using a syringe-like delivery system. In the wound, XSTAT® sponges expand and swell to fill the wound cavity, within 20 seconds of contact with blood, facilitating compression of bleeding structures. XSTAT® can be applied through skin wounds. The system can readily access deep vascular structures. While rapidly hemostatic, the hemostatic sponges are also relatively easy to remove. In the setting of junctional bleeding, XSTAT® may allow for hemostatic pressure generation from within the wound tract rat...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age ≥15 years or estimated body weight ≥50 kg.
• • 2. Penetrating junctional injury (femoral or axillary), with i. visible bleeding ii. too proximal to be controlled with a tourniquet
• • 3. Patient will be taken to participating level I trauma center, directly from the scene
• Exclusion Criteria:
• • 1. Prisoners, children \<15 years old, known pregnant patients.
• • 2. Patients receiving chest compressions (prior to XSTAT® use).
• • 3. Patients with an opt-out bracelet.